ATE455548T1 - Mittel und verfahren zum schutz, zur behandlung und reparatur von bindegewebe - Google Patents
Mittel und verfahren zum schutz, zur behandlung und reparatur von bindegewebeInfo
- Publication number
- ATE455548T1 ATE455548T1 AT08075016T AT08075016T ATE455548T1 AT E455548 T1 ATE455548 T1 AT E455548T1 AT 08075016 T AT08075016 T AT 08075016T AT 08075016 T AT08075016 T AT 08075016T AT E455548 T1 ATE455548 T1 AT E455548T1
- Authority
- AT
- Austria
- Prior art keywords
- protecting
- treating
- methods
- connective tissue
- repairing connective
- Prior art date
Links
- 210000002808 connective tissue Anatomy 0.000 title 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 abstract 1
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 abstract 1
- 102000005741 Metalloproteases Human genes 0.000 abstract 1
- 108010006035 Metalloproteases Proteins 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960003722 doxycycline Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000003367 polycyclic group Chemical group 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Reinforced Plastic Materials (AREA)
- Inorganic Insulating Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7459498P | 1998-02-13 | 1998-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE455548T1 true ATE455548T1 (de) | 2010-02-15 |
Family
ID=22120420
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08075016T ATE455548T1 (de) | 1998-02-13 | 1999-02-12 | Mittel und verfahren zum schutz, zur behandlung und reparatur von bindegewebe |
| AT99906947T ATE394108T1 (de) | 1998-02-13 | 1999-02-12 | Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99906947T ATE394108T1 (de) | 1998-02-13 | 1999-02-12 | Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1917966B1 (de) |
| JP (1) | JP2002502881A (de) |
| AT (2) | ATE455548T1 (de) |
| AU (1) | AU764431B2 (de) |
| CA (1) | CA2320202C (de) |
| CY (1) | CY1108110T1 (de) |
| DE (2) | DE69941966D1 (de) |
| DK (2) | DK1053000T3 (de) |
| ES (2) | ES2338946T3 (de) |
| PT (2) | PT1053000E (de) |
| WO (1) | WO1999040926A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6656925B2 (en) * | 1998-09-09 | 2003-12-02 | Advanced Medical Instruments | Composition and method of treating arthritis |
| DE20004010U1 (de) | 2000-03-02 | 2000-06-21 | Febena Pharma GmbH, 50825 Köln | Diätische Zusammensetzung mit einem Gehalt an Glycosaminoglycanen |
| DE10054257A1 (de) * | 2000-11-02 | 2002-05-16 | Kief Horst | Heilmittel zur Intraarticulären Injektion |
| FR2842738B1 (fr) * | 2002-07-23 | 2006-02-10 | Negma Lerads | Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus |
| US20050090551A1 (en) * | 2003-10-27 | 2005-04-28 | Board Of Trustees Of Southern Illinois University | Therapeutic use of methionine for the treatment or prevention of mucositis |
| JP2007525486A (ja) * | 2003-11-24 | 2007-09-06 | オプティマー・ファーマスーティカルズ・インコーポレイテッド | 化合物の投与による哺乳動物の症状の処置及び化合物の使用方法 |
| MX2007011931A (es) * | 2007-09-26 | 2009-03-26 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un agente antiartritico y un agente inhibidor de la interleucina-1, util para el control y tratamiento de la osteoartritis y enfermedades relacionadas. |
| US8455436B2 (en) | 2010-12-28 | 2013-06-04 | Depuy Mitek, Llc | Compositions and methods for treating joints |
| US8398611B2 (en) | 2010-12-28 | 2013-03-19 | Depuy Mitek, Inc. | Compositions and methods for treating joints |
| US8524662B2 (en) | 2010-12-28 | 2013-09-03 | Depuy Mitek, Llc | Compositions and methods for treating joints |
| US11000533B2 (en) | 2011-03-25 | 2021-05-11 | Trackside Technologies Pty Ltd. | Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue |
| AU2011363947B2 (en) * | 2011-03-25 | 2017-01-05 | Trackside Technologies Pty Ltd | Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue |
| US8623839B2 (en) | 2011-06-30 | 2014-01-07 | Depuy Mitek, Llc | Compositions and methods for stabilized polysaccharide formulations |
| US9682099B2 (en) | 2015-01-20 | 2017-06-20 | DePuy Synthes Products, Inc. | Compositions and methods for treating joints |
| BR112022014911A2 (pt) * | 2020-01-29 | 2022-09-20 | Lonza Consumer Health Inc | Composição de saúde articular e uso da mesma em mamíferos saudáveis |
| AU2023312374A1 (en) * | 2022-07-19 | 2024-12-12 | Suntory Holdings Limited | Oral composition, and method for suppressing bitterness originating from ergothioneine or salt thereof and odor originating from chondroitin sulfate or salt thereof |
| AU2023309945A1 (en) * | 2022-07-19 | 2024-12-12 | Suntory Holdings Limited | Oral composition, and method for suppressing bitterness derived from ergothioneine and off-flavor derived from glucosamine compound |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB856493A (en) * | 1957-10-04 | 1960-12-21 | Pfizer & Co C | Therapeutic compositions comprising tetracycline antibiotics |
| FR2193M (fr) * | 1962-09-10 | 1963-12-09 | Lipha | Nouveau médicament pour le traitement des maladies infectieuses. |
| US4925833A (en) * | 1983-12-29 | 1990-05-15 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis |
| US4704383A (en) * | 1983-12-29 | 1987-11-03 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
| GB8507058D0 (en) * | 1985-03-19 | 1985-04-24 | Efamol Ltd | Pharmaceutical & dietary compositions |
| JPS63203628A (ja) * | 1987-02-19 | 1988-08-23 | Taiyo Kagaku Co Ltd | 動物の乳房炎治療剤 |
| US5770209A (en) * | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
| US5258371A (en) * | 1992-05-29 | 1993-11-02 | Kuraray Co., Ltd. | Method to reduce connective tissue destruction |
| US5364845C1 (en) * | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
| FR2707087B1 (fr) * | 1993-06-28 | 1995-10-13 | Bioxytech | Nouveau procédé de préparation de l'ergothionéine. |
| GB9403857D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
| JPH09143492A (ja) * | 1995-11-17 | 1997-06-03 | Katsumasa Koike | 酸化脂質の確認方法及び酸化脂質の生成方法 |
| NL1003503C2 (nl) * | 1996-07-04 | 1998-01-07 | Negma Steba International Dev | Farmaceutische samenstelling voor orale toediening. |
| IT1288257B1 (it) * | 1996-11-29 | 1998-09-11 | Paoli Ambrosi Gianfranco De | Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico |
-
1999
- 1999-02-12 ES ES08075016T patent/ES2338946T3/es not_active Expired - Lifetime
- 1999-02-12 DE DE69941966T patent/DE69941966D1/de not_active Expired - Lifetime
- 1999-02-12 DE DE69938036T patent/DE69938036D1/de not_active Expired - Lifetime
- 1999-02-12 PT PT99906947T patent/PT1053000E/pt unknown
- 1999-02-12 AT AT08075016T patent/ATE455548T1/de active
- 1999-02-12 WO PCT/US1999/003019 patent/WO1999040926A1/en not_active Ceased
- 1999-02-12 DK DK99906947T patent/DK1053000T3/da active
- 1999-02-12 AU AU26740/99A patent/AU764431B2/en not_active Ceased
- 1999-02-12 JP JP2000531177A patent/JP2002502881A/ja active Pending
- 1999-02-12 DK DK08075016.9T patent/DK1917966T3/da active
- 1999-02-12 EP EP08075016A patent/EP1917966B1/de not_active Expired - Lifetime
- 1999-02-12 EP EP99906947A patent/EP1053000B1/de not_active Expired - Lifetime
- 1999-02-12 ES ES99906947T patent/ES2302373T3/es not_active Expired - Lifetime
- 1999-02-12 CA CA2320202A patent/CA2320202C/en not_active Expired - Fee Related
- 1999-02-12 PT PT08075016T patent/PT1917966E/pt unknown
- 1999-02-12 AT AT99906947T patent/ATE394108T1/de active
-
2008
- 2008-06-03 CY CY20081100577T patent/CY1108110T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1120211A1 (en) | 2009-03-27 |
| EP1053000A4 (de) | 2003-01-29 |
| CA2320202C (en) | 2010-09-14 |
| PT1917966E (pt) | 2010-03-17 |
| CA2320202A1 (en) | 1999-08-19 |
| EP1917966A1 (de) | 2008-05-07 |
| EP1053000B1 (de) | 2008-05-07 |
| DE69941966D1 (de) | 2010-03-11 |
| ATE394108T1 (de) | 2008-05-15 |
| DK1053000T3 (da) | 2008-09-01 |
| DK1917966T3 (da) | 2010-03-15 |
| PT1053000E (pt) | 2008-07-11 |
| EP1053000A1 (de) | 2000-11-22 |
| ES2338946T3 (es) | 2010-05-13 |
| DE69938036D1 (de) | 2008-03-13 |
| AU2674099A (en) | 1999-08-30 |
| JP2002502881A (ja) | 2002-01-29 |
| EP1917966B1 (de) | 2010-01-20 |
| ES2302373T3 (es) | 2008-07-01 |
| AU764431B2 (en) | 2003-08-21 |
| WO1999040926A1 (en) | 1999-08-19 |
| CY1108110T1 (el) | 2014-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE394108T1 (de) | Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe | |
| ATE477270T1 (de) | Verfahren und zusammensetzungen zur prävention und behandlung von anämie | |
| ATE257385T1 (de) | Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes | |
| DE69726289D1 (de) | Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit | |
| ATE224138T1 (de) | Zusammensetzungen und verfahren zur behandlung von pflanzen mit exogenen chemikalien | |
| DE69429369D1 (de) | Verfahren und mittel zur behandlung abnormaler zustände des epitheliums von körperöffnungen | |
| ATE284210T1 (de) | Verfahren und zusammensetzung zur behandlung von krebs | |
| ATE455092T1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
| ATE250576T1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
| EP0675723A4 (de) | Biphosphonat/östrogen-therapie zur behandlung und prävention von knochenverlust. | |
| ATA11989A (de) | Mittel zur vorbeugung gegen und behandlung von parodontopathien | |
| ATE362374T1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| DE69231592D1 (de) | Verfahren und zusammensetzungen zur behandlung von malaria und anderen erkrankungen | |
| DE60009665D1 (de) | Zusammensetzungen zur behandlung von entzündungsreaktionen | |
| DE69806579D1 (de) | Anlage zur behandlung von nahrungsmitteln | |
| DE69941821D1 (de) | Fluorenthaltende zusammensetzung zur behandlung von oberflächen | |
| EP1109548A4 (de) | Zusammensetzungen und verfahren zur behandlung und vorbeugung von knochenkrankheiten unter verwendung von tocotrienole | |
| DE69905616D1 (de) | Verfahren und zusammensetzung zur behandlung und vorbeugung von mycobacterium infektionen | |
| ATE190843T1 (de) | Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten | |
| DE69900339D1 (de) | Mittel und Verfahren zur Behandlung von Kunstfasern | |
| DE69808475D1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| DE69924741D1 (de) | Verwendung einer zusammensetzung zur herstellung eines arzneimittels zur vorbeugung und behandlung von parodontitis | |
| DE69535366D1 (de) | Zusammensetzung zur behandlung und vorbeugung von hiv-1 infektionen, welche mindestens zwei verschiedene hiv-1 reverse transcriptase inhibitoren enthalt | |
| DE69928501D1 (de) | Mittel zur vorbeugung/behandlung von osteoporose | |
| DE60028831D1 (de) | Zusammensetzungen und verfahren zur behandlung von epilepsie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1917966 Country of ref document: EP |